Below is a comprehensive archive of press releases from MSF-USA. Use the options in the boxes below to filter results based on your preferences.

Country/Region

Topic

April 05, 2017

NEW YORK, APRIL 5, 2017—A Doctors Without Borders/Médecins Sans Frontières (MSF) medical team supporting the emergency department at Bab Al Hawa Hospital in Syria's Idlib Province has confirmed that patients' symptoms are consistent with exposure to a neurotoxic agent.

April 03, 2017

DEMINING ACTIVITIES ARE URGENTLY NEEDED AS RETREATING FIGHTERS BOOBY-TRAP HOMES AND CIVILIAN AREAS

AMSTERDAM/NORTHERN SYRIA, APRIL 3, 2017—As the front lines shift in northern Syria, explosive devices and mines are having a devastating impact on civilians, the international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières warned in a report released today, calling for urgently needed demining activities.

March 31, 2017

NEW YORK, MARCH 31, 2017—A hospital in northern Syria that receives support from the international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) was bombed on March 25, killing two people and causing severe respiratory symptoms among patients and staff, MSF said today, denouncing the attack.

March 27, 2017

First patent opposition MSF has filed in Europe aims to increase affordable access to hepatitis C drug sofosbuvir for millions

NEW YORK/ROME/GENEVA, MARCH 27, 2017—In an effort to increase access to affordable hepatitis C treatment, the international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) filed a patent challenge on the lifesaving hepatitis C drug sofosbuvir with the European Patent Office (EPO) today.

March 24, 2017

NEW YORK, MARCH 24, 2017—Today, World Tuberculosis Day, Doctors Without Borders/Médecins Sans Frontières’ (MSF) is urging pharmaceutical corporations, Sequella and Pfizer, to provide open access to all existing clinical data on a promising drug, sutezolid, to help accelerate the research and development of urgently needed new, lifesaving TB treatment regimes. This data, if not released, will take years and resources to replicate, further delaying new treatment options for people living with TB.

March 23, 2017

Companies and countries must take urgent action to increase access to these lifesaving treatments

March 22, 2017

NEW YORK, MARCH 22, 2017—A new, heat-stable vaccine is safe and effective against rotavirus, according to results of a recent Doctors Without Borders/Médecins Sans Frontiéres vaccine trial in Niger, published in the New England Journal of Medicine Thursday.

March 22, 2017

ERBIL, IRAQ/NEW YORK, MARCH 22, 2017—Tens of thousands of people are fleeing western Mosul, Iraq, amid a military offensive to recapture the area, with many wounded in the crossfire or suffering from other emergency medical needs, the international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) said today.

March 14, 2017

Massive needs are not met as large areas are out of reach.

March 08, 2017

BRUSSELS/BELGRADE/NEW YORK—In recent months, Doctors Without Borders/Médecins Sans Frontières (MSF) teams in Serbia have treated an increasing number of patients reporting widespread violence and cruel and degrading treatment allegedly perpetrated by Hungarian authorities at the Serbian/Hungarian border, MSF said today, calling on Hungarian authorities to investigate and take immediate action to stop these brutal practices.

Pages